These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. hCAP-D3 expression marks a prostate cancer subtype with favorable clinical behavior and androgen signaling signature. Lapointe J; Malhotra S; Higgins JP; Bair E; Thompson M; Salari K; Giacomini CP; Ferrari M; Montgomery K; Tibshirani R; van de Rijn M; Brooks JD; Pollack JR Am J Surg Pathol; 2008 Feb; 32(2):205-9. PubMed ID: 18223322 [TBL] [Abstract][Full Text] [Related]
7. [Research at the Ulm University in prostate cancer]. Rinnab L; Cronauer M; Spindler D; Hautmann RE; Küfer R Urologe A; 2007 Sep; 46(9):1071-7. PubMed ID: 17628778 [No Abstract] [Full Text] [Related]
8. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996 [TBL] [Abstract][Full Text] [Related]
9. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer. Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593 [TBL] [Abstract][Full Text] [Related]
10. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer. Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
13. Molecular biologic aspects of human prostatic carcinoma. Netto GJ; Humphrey PA Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S57-64. PubMed ID: 7942612 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal analysis of androgen deprivation of prostate cancer cells identifies pathways to androgen independence. D'Antonio JM; Ma C; Monzon FA; Pflug BR Prostate; 2008 May; 68(7):698-714. PubMed ID: 18302219 [TBL] [Abstract][Full Text] [Related]
15. [Cancer--a disease of the genes]. Sauter G Praxis (Bern 1994); 1998 Apr; 87(16):535-7. PubMed ID: 9600016 [No Abstract] [Full Text] [Related]
16. Validation of molecular targets in prostate cancer. Schalken JA BJU Int; 2005 Dec; 96 Suppl 2():23-9. PubMed ID: 16359435 [TBL] [Abstract][Full Text] [Related]
17. PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor. Litvinov IV; Antony L; Dalrymple SL; Becker R; Cheng L; Isaacs JT Prostate; 2006 Sep; 66(12):1329-38. PubMed ID: 16835890 [TBL] [Abstract][Full Text] [Related]
18. [Prostate cancer: cytogenetic and molecular biology principles]. Strohmeyer T; Effert P Med Klin (Munich); 1993 Aug; 88(8):482-4. PubMed ID: 8413050 [No Abstract] [Full Text] [Related]
19. Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate. Kinoshita M; Nakagawa T; Shimizu A; Katsuoka Y Int J Urol; 2005 Apr; 12(4):390-7. PubMed ID: 15948728 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines. Tørring N; Jørgensen PE; Sørensen BS; Nexø E Anticancer Res; 2000; 20(1A):91-5. PubMed ID: 10769639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]